Experiments in mice showed that the treatment of ATC xenograft mice with anti-CD47 antibody increased TAM frequencies, enhanced expression of macrophage activation markers, enhanced tumor cell phagocytosis, and inhibited tumor growth. Here, CD47 is linked to neoplasm.